A real-world study to assess the disease control of moderate to severe atopic dermatitis in patients receiving dupilumab therapy, with atopic dermatitis control tool in Gulf countries

A real-world study to assess the disease control of moderate to severe atopic dermatitis in patients receiving dupilumab therapy, with atopic dermatitis control tool in Gulf countries

Purpose/aim of the study There is limited real-world evidence regarding the effectiveness and safety of dupilumab in Gulf countries. The study aimed to evaluate atopic dermatitis (AD) disease control in adult and adolescent patients (≥12 years) treated with dupilumab in Gulf countries.Materials and...

Full description

Saved in:
Bibliographic Details
Main Authors: Amani Alfalasi, Ahmed Ameen, Atlal Al Lafi, Ayman El Gendi, Waqas Saad, Ahmed Ismail, Ayman Al Naeem, Srikumar Goturu, Nasser Al-Ahmed, Hussein Abdel Dayem, Arti Nanda, Amira Tawdy, Lulwa Alogayell, Mohamed Iraqi, Nasser Abdul Hay, Manar El Enezi, Subash Walkhinde, Marwa Kamal, Muna Aldhuhoori, Asem Almesfer, Amira Abd Elwhab, Khalid Ali Al Hawsawi, Ahmad Barakat, Sahar Chmayse, Mohammed Hafiz, Zahir Chouikrat, Monica Fahmy
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Journal of Dermatological Treatment
Subjects:
Atopic dermatitis
itch
dupilumab
ADCT
real-world evidence
gulf
Online Access:https://www.tandfonline.com/doi/10.1080/09546634.2024.2443110
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.tandfonline.com/doi/10.1080/09546634.2024.2443110

Similar Items